Icon

PREZISTA (nda021976)- (75MG,150MG,300MG,400MG,600MG,800MG)

DARUNAVIR JANSSEN PRODS
75MG,150MG,300MG,400MG,600MG,800MG
Yes No
2027-Jun-26 2011-Jun-23
None None
None No
PREZISTA is a human immunodeficiency virus (HIV-1) protease inhibitor indicated for the treatment of HIV-1 infection in adult and pediatric patients 3 years of age and older. PREZISTA must be co-administered with ritonavir (PREZISTA/ritonavir) and with other antiretroviral agents.
9 11 9
Total Other Developers 11
Drugs with Suitability No
75MG ** ** - - -
150MG ** ** - - -
300MG ** ** - - -
400MG ** ** - - -
600MG ** ** Up - 9
800MG ** ** Up - 7
NDA Sales Available Total Generic Sales Available
No 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** **** *** *** ****** **** ******* *********** **** ***, **** **. **-***, ****-**, ***, **********, *********, ********* ******, ***** (***) ***
****** **** ****** *** ***** ******** *.*.*. *********** ****** ****** ********** **, ******, *****, ******* (***) ***
****** ***** *** ***** ******* *********** ****-*, **** **. ***, ***, ****** - **, ******* ******** ****, *****, ******, *********** ******, ***** (***) ***
****** ***** ***** ******* *** *********** **** *-*, *-**, *-** **** ********** ****, ******** *******, ******-*****, ****, *********** ******, ***** (***) ***
****** ***** ******* ***************, *** *********** *** * ******** *****, ******* *****, *** **** (**) *****, ****** ****** (***) ***
****** ** ****** ****** **** ******* *********** **** **. **, ** & **, ******* ****** ***** *********** *******, ******** ******, **********, ****** ******* ******, ***** (***) ***
****** *** *** ************ ******* ******* *********** ************ ********, ****-**, ****** ***. ****& **** ** ****, ********* (*******), ********* (******), ********** ********, ********* ******, ***** (***) ***
****** ***** ************ ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***
****** ********* ****** *** *** ********** ******* *********** ****-**, **** **.**, *****, *.*.***, ******** *******, ********* ******, ******** ********, ********, ****** ******* ******, ***** (***) ***
****** ****** ****** *************** ******* ******* *********** **** ** ** & **, ******* ******* ******** **** *******-***** *.*. **. **, ***.: ******, ***.: ******, *********, ** ******, ***** (***) ***
CIPLA 69097-248 CIPLA LIMITED 917066446 Api manufacture Plot D-7, D-22, D-27 MIDC Industrial Area, Kurkumbh Village, Taluka-Daund, Pune, Maharashtra 413802, India (IND) IND
CIPLA 69097-248 CIPLA LIMITED 916940208 Manufacture Plot No. A-2, A-33, A-42 and A-37/2/2, Patalganga Industrial Area, Raigad, Maharashtra 410220, India (IND) IND
CIPLA 69097-248 INVAGEN PHARMACEUTICALS, INC 080334903 Manufacture 550 S Research Place, Central Islip, New York (NY) 11722, United States (USA) USA
CIPLA 69097-244 CIPLA LIMITED 917066446 Api manufacture Plot D-7, D-22, D-27 MIDC Industrial Area, Kurkumbh Village, Taluka-Daund, Pune, Maharashtra 413802, India (IND) IND
CIPLA 69097-244 CIPLA LIMITED 916940208 Manufacture Plot No. A-2, A-33, A-42 and A-37/2/2, Patalganga Industrial Area, Raigad, Maharashtra 410220, India (IND) IND
CIPLA 69097-244 INVAGEN PHARMACEUTICALS, INC 080334903 Manufacture 550 S Research Place, Central Islip, New York (NY) 11722, United States (USA) USA

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.